Not Signed In - Results Of Phase 2 Study Of Tolevamer For C. Difficile-Associated Diarrhea Published In Clinical Infectious Diseases
Wed, 16 Aug 2006 07:00 AM EST
... Genzyme Corporation(Nasdaq: GENZ) announced today that results from its phase 2 trial oftolevamer, an investigational polymer therapy for patients with Clostridiumdifficile-associated diarrhea (CDAD), have been published in the August 15issue of Clinical Infectious Diseases. [click link for full article] ...
Related Topics
- Infectious Diseases
- Clinical Trials
- Diarrhea
- Emerging Infectious Diseases
- Epidemiology & Prevention of Vaccine-Preventable Diseases
- Mononucleosis, Infectious
- Infectious Diseases (General)
- Vector Borne Infectious Diseases
- Pharmacology
- Epidemiology
- Clostridium Difficile Infection
- Psychopharmacology
- Sexually Transmitted Diseases
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Brainerd Diarrhea
- Eye Diseases
- Clinical Growth Charts
- Infectious Mononucleosis
- Cardiovascular Diseases And Disorders
email this page
print this page
bookmark this page
feedback on this page
